Cargando…

Design and heterologous expression of a novel dimeric LL37 variant in Pichia pastoris

BACKGROUND: The antimicrobial peptide LL37 is produced by white blood cells (mainly neutrophils) and various epithelial cells, and has the outstanding advantages of participating in immune regulation, causing chemotaxis of immune cells and promoting wound healing. However, the central domain of LL37...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhan, Na, Zhang, Licong, Yang, Hong, Zheng, Yalan, Wei, Xinke, Wang, Jiajun, Shan, Anshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305873/
https://www.ncbi.nlm.nih.gov/pubmed/34301247
http://dx.doi.org/10.1186/s12934-021-01635-x
Descripción
Sumario:BACKGROUND: The antimicrobial peptide LL37 is produced by white blood cells (mainly neutrophils) and various epithelial cells, and has the outstanding advantages of participating in immune regulation, causing chemotaxis of immune cells and promoting wound healing. However, the central domain of LL37 needs to be improved in terms of antimicrobial activity. RESULTS: In this study, the amino acid substitution method was used to improve the antimicrobial activity of the LL37 active center, and a dimeric design with a better selection index was selected. A flexible linker was selected and combined with the 6 × His-SUMO tag and LG was successfully expressed using Pichia pastoris as a host. Recombinant LG displayed strong antimicrobial activity by destroying the cell membrane of bacteria but had low hemolytic activity. In addition, compared with monomeric peptide FR, rLG had improved ability to tolerate salt ions. CONCLUSION: This research provides new ideas for the production of modified AMPs in microbial systems and their application in industrial production. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12934-021-01635-x.